Novel l-Prolinamide Derivatives as Selective PI3Kα Inhibitors

A series of novel disubstituted l-prolinamide derivatives were designed and synthesized to target PI3Kα, a protein frequently mutated in cancers. The dataset includes biological evaluation data, showing compound 26 exhibited high selectivity over other PI3K isoforms (1268-fold over PI3Kβ). It was authored by Yunxia Wang and last updated on March 18, 2026.

Use Cases

• Train QSAR models based on the described l-prolinamide derivative structures.
• Benchmark molecular docking simulations against the reported PI3Kα selectivity data.
• Analyze structure-activity relationships for PI3Kα inhibition based on the synthesized compound series.

Strengths

• Includes specific selectivity fold-change metrics (e.g., 1268-fold over PI3Kβ).
• Data is associated with a published study on preclinical anticancer potential.
• File size is 8.9 KB, indicating a focused and manageable dataset.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

figshare, author Yunxia Wang

Collection Method

Likely contains experimental data from the synthesis and biological evaluation of chemical compounds.

Freshness

Last updated 2026-03-18 12:38:45; freshness should be verified.